Study of MediReg® for severe male infertility
Part of Kidney & urinary clinical trials.
This study tests an experimental medicine called MediReg® for men with severe infertility who have not been able to conceive. It aims to see if the drug is safe and can improve sperm quality, possibly offering a new option for men who have not had success with other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 21 and 60 years old.
- You have a severe sperm problem (very low count, poor movement, or high DNA damage) that has lasted at least 12 months.
- You and your partner have been unable to get pregnant for at least 12 months, even with treatments like IVF, or you have decided not to use those treatments.
- You are willing to use two birth control methods (including a condom) until at least 1 month after the study ends.
- You do not have genetic causes of infertility, blocked sperm ducts, active infections, recent heart problems, cancer, or other serious health conditions listed in the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two medicines—isotretinoin and human chorionic gonadotropin (hCG)—to see if they can improve sperm production in men with low sperm counts or no sperm due to certain causes. It might help if you haven't responded to other treatments before.
This trial tests if a supplement made from Tribulus Terrestris (a plant) can help men with low sperm count (oligospermia) improve their fertility. It may be an option for men who are considering hormone treatments.
This study tests an investigational drug called STSP-0902, given as multiple doses, to see if it can improve sperm count and movement in men with low sperm count or reduced sperm motility. It aims to help men who have no known cause for their infertility.
This study tests a new medication called leflutrozole for men with a condition where no sperm is produced (azoospermia). The drug may help increase hormone levels that support sperm production, potentially improving fertility.
This study tests a new oral medication (PKB171) compared to a placebo for couples who have mild male infertility and have not tried IVF/ICSI before. The goal is to see if PKB171 can help them conceive naturally.
This study tests a new drug called STSP-0902 to see if it is safe in healthy men. It may help men with low sperm count or poor sperm movement, but the main goal is to check for side effects.
Hear when a new Azoospermia, Nonobstructive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.